389 related articles for article (PubMed ID: 25877909)
1. Osteonecrosis of the jaws.
Toole J
Rheumatology (Oxford); 2015 Oct; 54(10):1755-6. PubMed ID: 25877909
[No Abstract] [Full Text] [Related]
2. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the Jaw.
Hamdy RC
J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
[No Abstract] [Full Text] [Related]
4. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
Sidhu HK
Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
[TBL] [Abstract][Full Text] [Related]
6. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
Thompson E; Sheehy C; Barry M; Carey J
Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
[No Abstract] [Full Text] [Related]
7. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
8. Managing the adverse effects of bisphosphonate therapy on the jaw.
Rizzolo D; Sedrak M
JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
[No Abstract] [Full Text] [Related]
9. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.
Chan BH; Yee R; Puvanendran R; Ang SB
Singapore Med J; 2018 Feb; 59(2):70-75. PubMed ID: 29568850
[TBL] [Abstract][Full Text] [Related]
11. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
12. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw.
Fantasia JE
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):547-53. PubMed ID: 26515736
[TBL] [Abstract][Full Text] [Related]
13. [Inflammation of the jaws during treatment with bisphosphonates].
Bartl R
Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
[No Abstract] [Full Text] [Related]
14. Bisphosphonate related osteonecrosis of the jaws.
Fung E
J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
[No Abstract] [Full Text] [Related]
15. Osteoporosis medications and your dental health.
J Am Dent Assoc; 2011 Nov; 142(11):1320. PubMed ID: 22041419
[No Abstract] [Full Text] [Related]
16. [The risk of bisphosphonate-related osteonecrosis of the jaw].
Polymenidi I; Trombetti A; Carballo S
Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
[TBL] [Abstract][Full Text] [Related]
17. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
Khan AA; Morrison A; Kendler DL; Rizzoli R; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S; Watts NB; Brandi ML; Peters E; Guise T; Eastell R; Cheung AM; Morin SN; Masri B; Cooper C; Morgan SL; Obermayer-Pietsch B; Langdahl BL; Dabagh RA; Davison KS; Sándor GK; Josse RG; Bhandari M; El Rabbany M; Pierroz DD; Sulimani R; Saunders DP; Brown JP; Compston J;
J Clin Densitom; 2017; 20(1):8-24. PubMed ID: 27956123
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and the risk of osteonecrosis of the jaw.
Favus MJ
J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
[No Abstract] [Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaws.
Kushner GM; Alpert B
Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
[TBL] [Abstract][Full Text] [Related]
20. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
Hanley DA; McClung MR; Davison KS; Dian L; Harris ST; Miller PD; Lewiecki EM; Kendler DL;
Am J Med; 2017 Jul; 130(7):862.e1-862.e7. PubMed ID: 28359721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
